Allergy Care Market

Allergy Care Market Outlook (2022-2032)

The global allergy care market is estimated at USD 22 Billion in 2022 and is forecast to surpass USD 40 Billion by 2032, growing at a CAGR of 6.1% from 2022 to 2032. The global allergy care market accounts for ~<1% of the global healthcare market in 2022.

The allergy treatment market is anticipated to grow rapidly during the forecast period. Allergies, after cancer, AIDS, and cardiovascular illnesses, are the fourth most common global pathologic condition, as per the World Health Organization (WHO).

Allergens can induce hay fever, allergic rhinitis, asthma, atopic dermatitis, and other allergic disease disorders. Itching in the nose, roof of mouth, throat, or eyes, as well as sneezing, stuffy nose (congestion), teary eyes, and other symptoms, are all common indications of allergic reactions.

On the back of a developing interdisciplinary approach to allergy diagnosis, the allergy treatment market has grown quickly over the last few decades. Anaphylaxis is characterized by severe symptoms, bee stings, peanuts, latex, and small molecule and immunological medicines are only a few of the many triggers. The study of allergy pathophysiology has aided in the expansion of the allergy treatment market. Increased vascular permeability, face flushing, and bronchoconstriction are all life-threatening signs.

Furthermore, food allergies can result in symptoms such as vomiting, diarrhea, or respiratory problems when an allergen is consumed.

Another significant factor influencing the growth rate of allergy treatment market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

The global allergy care market is projected to have an absolute $ opportunity of USD 17 Billion during the assessment period of 2022-2032.

Report Attributes	Details
Anticipated Base Year Value (2021)	US$ 20.85 Billion
Expected Market Value (2022)	US$ 22 Billion
Projected Forecast Value (2032)	US$ 40 Billion
Global Growth Rate (2022-2032)	6.1% CAGR
Expected Market Share of the North America Market (2032)	23.8%
Anticipated CAGR of Europe (2022-2032)	5%
Major Allergy care Service Providers	Johnson & Johnson Services, Inc. Sanofi Aventis U.S. LLC Bayer AG Spirit Pharmaceuticals LLC Abbott Merck & Co. Inc. GlaxoSmithKline plc LETIPharma Genentech USA, Inc. ALK-Abelló A/S

2017-2021 Global Allergy Care Market Outlook in Comparison to 2022-2032 Growth Forecast

Increased incidences for allergies caused by hypersensitivity to allergens such as dust, mold, mite and sometimes milk, wheat, egg etc. was noted in recent times.

Due to which, enhanced focus towards cure and prevention of allergies came into the trend. Both the aforementioned factors led to augmented investment by allergy care manufacturers along with advanced products offered by them in their product portfolio. This boosted the growth of global allergy care market by multiplication factor of 1.6X during assessment period of 2017-2021.

Manufacturers of allergy care are adopting key marketing strategies to gain a larger market share. Strategies such as increasing production capacities by expanding manufacturing facilities, collaborating with healthcare professionals to carry out clinical research and development are likely to boost sales of allergy care products.

Moreover, solidifying regional presence by offering products in specific segments such as nasal sprays and eye drops to cure allergies is likely to multiply revenue earned by these manufacturers by 1.5X factor within upcoming half-decade.

Fact.MR estimates that the global allergy care products are likely to witness exhibiting growth at 6.1% CAGR during 2022-2032 which is supposed to multiply the historical market valuation that grew with a CAGR of 3.2% during 2017-2021.

Which are Some Prominent Drivers Allergy Care Market?

Technology Infusion in Allergy Care Gains Solidity

Patient-physician collaboration is getting enhanced with the use of technologies such as telehealth and telemedicine in allergy care. This trend is gaining prominence in the case of allergy care, where health care specialists are able to treat multiple patients within a stipulated time period leading to enhanced clinical outcomes.

In addition to this, improved efficiency and customer satisfaction offered by products incurred with such technologies assisted prominent authorities like the American College of Allergy, Asthma and Immunology (ACAII), to support the use of telehealth and telemedicine in the allergy care market. This is likely to contribute nearly 2.2X to overall allergy care market growth.

A Paradigm Shift: Cure to Prevention

Allergy cases are witnessing a rapid upsurge and substantial dependence on pharmacotherapy for a cure seems unfeasible. Allergies are the 6th leading cause of chronic illness in the United States, according to the Center for Disease Control and Prevention (CDC). Furthermore, more than 55 Billion of the population suffer from allergies in one way or the other.

In addition to this, ~165 Billion Europeans suffer from allergic diseases and approximately 50% of the EU population is expected to be affected by the same by 2025, according to the European Academy of Allergy and Clinical Immunology (EAACI).

Thus, consumers are focusing on preventive allergy care, which is likely to support market growth by 2.1X during the assessment period of 2022-2032. Moreover, preventive care product development carries promising potential and lucrative opportunities for players to tap into.

What are the Challenges Faced by the Allergy Care Market?

Limited awareness about allergic conditions may impede allergy care administration

Lack of awareness about the impact of allergic conditions is the chief reason for them being underdiagnosed and underestimated, despite their high prevalence. However, there have been numerous initiatives carried out by organizations such as the European Federation of Allergy and Airway Diseases Patients Associations (EFA) to introduce awareness programs that are likely to underpin allergy care market growth.

Comparative View of Allergy Care Markets

Allergy care Market :

Attributes	Allergy care Market
CAGR (2022-2032)	6%
Market Value (2032)	US$ 140 Billion
Growth Factor	Advanced chromatography machines along with research activities is bolstering the demand for allergy care.
Opportunity	Increasing research activities for treatment of diseases across the globe is creating lucrative opportunities for allergy care.

OTC Cold, Cough and Allergy Market :

Attributes	OTC Cold, Cough and Allergy Market
CAGR (2022-2032)	5.5%
Market Value (2032)	US$ 66.54 Billion
Growth Factor	Accessibility, affordability, and the presence of many retail stores offering OTC Cough, Cold and allergy products is creating lucrative opportunities for OTC cold, cough and allergy market.
Opportunity	Development of Anti-congestants and cough suppressant tablets, balms, rubs, syrups, and nasal drops is fueling the growth of OTC cold, cough and allergy market.

Region-wise Insights

Prevalence of Allergies Contributing to Allergy Care Market Growth in North America?

Asthma and allergies driving growth of regional allergy care market

North America allergy care market is dominant in the overall market. It contributes approximately 23.8% to the overall market share and is poised to continue on the same trajectory.

In North America, the United States is the dominant country contributing approximately 19.2% to the overall market share. According to the survey conducted by the Asthma and Allergy Foundation of America in the year 2020, concluded that more than 63% of consumers had allergies, more than 55% had asthma, and more than 65% of them had a family member with some form of allergy.

In addition to this, according to the Food Allergy Research & Education report of 2020, estimated that more than 31 Billion United States residents were prone to food allergies and more than 38% of children are food allergic to more than one food.

Thus, all the above-listed factors are poised to place 1.5X demand for allergy care from the North America.

How allergy prevalence in Europe is proving to be a burden on productivity and daily living?

Immediate requirement for treating allergies boosting growth of European allergy care market

More than 145 Billion EU citizens are expected to suffer from allergic diseases. Growing urbanization and industrialization, leading to pollution and climate change, are considered to be the chief reasons behind the increasing prevalence of allergic diseases. This number is estimated to escalate exponentially where more than 50% of all Europeans with no age, social and geographical distinction are anticipated to suffer from it by 2025.

Allergic diseases and reactions are creating social and economic impact wherein, they hinder the quality of life, reduce productivity and has a negative impact on output, thus impacting the business and national economy of Europe.

According to The European Academy of Allergy and Clinical Immunology (EAACI), more than 100 Billion workdays and school days are lost due to asthma and allergic rhinitis. Additionally, insufficiently treated allergic reactions lead to 50 billion to 145 billion loss of euros per annum.

Thus, the focus is being laid on cost-effective allergy care and treatment, generating average savings of nearly USD 158 billion per annum thus, triggering market demand in Europe by 1.3X.

Country-wise Forecast CAGRs for the Allergy Care Industry

Country	CAGR
U.S.	5%
Canada	4%
France	3%

Category-wise Insights

Food Allergy in Children Influencing Demand for Allergy Care?

Research and development contributing to growth of food allergy

Increased cases of food allergies are being witnessed in both children and adults across the globe. This rise in allergic diseases is expected to enhance the demand for food allergy prevention and care.

In addition to this, a greater focus on research and development to offer advanced products to consumers to cater to medical needs are likely to contribute to 2/5th of overall allergy care market demand.

Is Effective Management of Allergies Increasing Dependency on Antihistamine Medications?

Antihistamine medication beneficial for treatment of allergies

Allergy care is available in three product types under which antihistamine medications are demanded in high numbers. Technically, revenue from antihistamine medications are expected to be approximately 1.4X from that of nasal sprays product type segment.

Factors such as effective management of allergies such as rhinitis, urticarial, conjunctivitis, incorporation of fewer sedative antihistamines in the market are driving additional demand from this segment.

Availability of Wide Variety of Kits Fueling Drugs and Pharmacies Store Growth?

Convenience buying increasing sales from drugs and pharmacy stores

Allergy care is available through multiple sales channels, amongst which drug & pharmacies stores are likely to retain their dominant position in the global allergy care market sales. This segment accounts for 52.4% of the global market share.

Drug & pharmacies stores sales segment is poised to witness CAGR of 4.1% in the forecast years due to factors such as the availability of a wide variety of kits in stores, devoid of the need of prescription etc.

Start-Ups in Allergy Care Market

Key start-up players in the allergy care market are Aimmune Therapeutics, Third Harmonic Bio, Pulmocide, Connect Biopharma, and GentiBio

• Connect Biopharma, a key player in the allergy care start-up is focusing on offering medication for the treatment of autoimmune diseases and inflammation.
• Aimmune Therapeutics, another key player in the allergy care market is a clinical-stage biopharmaceutical company that develops products for the treatment for peanut and other allergies.

Market Competition

The global allergy care market is highly fragmented and competitive owing to the existence of many domestic and regional players. Various marketing strategies are adopted by key players such as mergers and acquisitions, expansions, collaborations and partnerships.

Also, new product development as a strategic approach is adopted by the leading companies to upscale their market presence among consumers. These strategies have resulted in the incorporation of advanced allergy care products.

Fact.MR has provided detailed information about price points of top manufacturers of allergy care positioned across regions, sales growth, production capacity, and speculative technological expansion in the recently published report.

For instance :

• Biologics License Application for Xolair prefilled syringes for self-injection product of Genentech, a member of Roche Group was approved by U.S. Food and Drug Administration (FDA), in 2021. The innovative product is designed for the treatment of moderate to severe allergic asthma, nasal polyps, and chronic idiopathic urticarial (CIU) as it targets and blocks IgE i.e. Immunoglobulin E.
  • Glenmark Pharmaceuticals Ltd. And Hikma Pharmaceuticals entered into a licensing agreement in 2020 to commercialize nasal spray for curing allergic rhinitis in the United States.

Key Segments Profiled in the Allergy Care Industry Survey

• By Type :

  • Eye Allergy
  • Skin Allergy
  • Food Allergy
  • Other Allergies (Rhinitis)

• By Product Type :

  • Nasal Spray
  • Antihistamine Medication
  • Eye Drops

• By Form :

  • Tablet/Gels/Pills
  • Sprays
  • Liquids

• By Sales Channel :

  • By Drug & Pharmacies Stores
  • By Modern Trade
  • By Departmental Stores
  • By Institutional Sales
  • By Monobrand Stores
  • By Online Retailers

• By Region :

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East & Africa